Jiangxi Huaxing established on Oct., 2005, is an earliest and largest integrated independent medical laboratory in Jiangxi province. It supplies professional outsourcing services such as medical inspection and pathological diagnosis for multi-level medical institutes which covered almost 600 hospitals and institutes with over 50% of occupancy in local market.

Dian Diagnostics indicated that the investment for this time is another significant measure for chain expansion for the third party of medical diagnostic outsourcing service business. By means of the investment, the company starting from a base rapidly distributed the laboratory net in Jiangxi province and obtained obvious leading advantage in this area improving the strategic layout in East China further, upgrading the outsourcing service occupancy for the third party medical diagnosis and enhancing sustainable development and core competitive power.

According to analysis, facing to the technological upgrading requirement for new commercial activities in clinical inspection industry, Dian Diagnostics positively promotes the transformation and application for high-end inspection fields, like genetic, molecular pathology, etc., meanwhile, it accelerates channel integration to invest or purchase several sub-distributors such as Bosheng Bio, Beijing Zhixin, Jinhua Freda, and holding Shengshi Kehua to speedy its expansion, which increasing the company` s performance obviously.

According to its quarterly reports on the first season, the revenue was ￥636 million on the first season of 2016 increasing 93.21% on year-on-year basis with ￥40 million net profit increasing 48.72% on YOY basis belongs to headquarter.